Rechercher
Rechercher
Journalism from the heart of crises
  1. Accueil
  2. Southern Africa
  3. South Africa
  • News

German car makers spend big on AIDS

    JOHANNESBURG
    German car makers in South Africa are spending big money on anti-AIDS drugs, treatment and education to tackle the pandemic among their workforce, Reuters reported on Thursday. Staying true to its motto, "HIV/AIDS Is Everybody's Business", Daimler Chrysler South Africa (DCSA) spends over US $420,000 annually to provide antiretroviral drugs to an estimated nine percent of its HIV-positive workforce. DCSA said it hoped the programme would reduce costs related to lost production through absenteeism, the hiring and training of new workers, and claims on company insurance funds. Mike Folan, the Group human resources manager for DCSA, said: We decided on giving antiretroviral drugs to our employees because of the government's policy at the time, [which] wasn't providing antiretroviral therapy."

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Partager cet article

    Get the day’s top headlines in your inbox every morning

    Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

    DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

    Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

    It’s the perfect way to start your day.

    Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join